Wilson's disease

Seminars in Liver Disease

Volumn 20, Issue 3, 2000, Pages 353-364

  Loudianos, G ^a   Gitlin, J D ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Copper; Liver; Wilson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CERULOPLASMIN; COPPER; PENICILLAMINE;

APOPTOSIS; AUTOSOMAL RECESSIVE DISORDER; CELL STRAIN HEPG2; CERULOPLASMIN BLOOD LEVEL; CHELATION THERAPY; CHROMOSOME 13; CLINICAL FEATURE; COPPER METABOLISM; DISEASE COURSE; GENE MUTATION; HOMEOSTASIS; HUMAN; IMMUNOBLOTTING; LIVER TRANSPLANTATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; TREATMENT OUTCOME; WILSON DISEASE;

EID: 0033744556     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9389     Document Type: Review

References (106)

1. Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver
2. The copper and iron content of the liver and brain in the normal and hepatolenticular degeneration
3. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration
4. A genetical analysis of 30 families with Wilson's disease
5. Assignment of the gene for Wilson's disease to chromosome 13: Linkage to the esterase D locus
6. The Wilson's disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene
7. The Wilson's disease gene is a copper transporting ATPase with homology to the Menkes disease gene
8. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson's disease
9. Iron and copper in yeast and it's relevance to human disease
10. Responseive-to-antagonist 1, a Menkes/Wilson's disease-related copper transporter, is required for ethylene signaling in Arabidopsis
11. A copper cofactor for the ethylene receptor ETR1 from Arabidopsis
12. Molecular mechanisms of copper homeostasis
13. A delicate balance: Homeostatic control of copper uptake and distribution
14. Clinical manifestations of nutritional copper deficiency in infants and children
15. Delivering copper inside yeast and human cells
16. Intracellular pathways of copper trafficking in yeast and humans
17. Copper uptake and assessmant of copper status
18. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism
19. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux
20. Molecular characterization of a copper transport protein in S. cerevisiae: An unexpected role for copper in iron transport
21. A widespread transposable element masks expression of a yeast copper transport gene
22. Molecular characterization of a putative Arabidopsis thaliana copper transporter and its yeast homologue
23. hCTR1: A human gene for copper uptake identified by complementation in yeast
24. A copper-sensing transcription factor regulates iron uptake genes in Schizosaccharomyces pombe
25. Hepatobiliary transport: Molecular mechanisms of development and cholestasis
26. Biochemical characterization of the Wilson's disease protein and functional expression in the yeast Saccharomyces cerevisiae
27. Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver
28. Localization of the Wilson's disease protein in human liver
29. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin
30. Organization of P-type ATPases-significance of structural diversity
31. CPx-type ATPases: A class of P-type ATPases that pump heavy metals
32. Functional expression of the Menkes disease protein reveals common biochemical mechanisms among the copper-transporting P-type ATPases
33. Role of the copper-binding domain in the copper transporet function of ATP7B, the P-type ATPase defective in Wilson's disease
34. Correction of the copper transport defect of Menkes patient fibroblasts by expression of the Menkes and Wilson ATPases
35. Solution structure of the fourth metal-binding domain from the Menkes copper-transporting ATPase
36. A study of Wilson's disease mutations in Britain
37. Mutation analysis in patients with Wilson's disease: Identification of 4 novel mutations
38. Novel ATP7B mutations causing Wilson's disease in several Israeli ethnic groups
39. Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson's disease
40. Characterization of the Wilson's disease gene encoding a P-type copper transporting ATPase: Genomic organization, alternative splicing, and structure/function predicting
41. Wilson's disease mutations associated with uncommon haplotypes in Mediterranean patients
42. Haplotype and mutation analysis in Greek patients with Wilson's disease
43. Mutation analysis in patients of Mediterranean descent with Wilson's disease: Identification of 19 novel mutations
44. Haplotype and mutation analysis in Japanese patients with Wilson's disease
45. Identification and analysis of mutations in the Wilson's disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses
46. A novel RNA splicing mutation in Japanese patients with Wilson's disease
47. The Wilson's disease gene: Spectrum of mutations and their consequences
48. Mutation analysis of Wilson's disease in Taiwan and description of six new mutations
49. Efficient detection of mutations in Wilson's disease by manifold sequencing
50. A novel pineal night-specific ATPase encoded by the Wilson's disease gene
51. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase
52. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein
53. Isolation of a partial candidate gene for Menkes disease by positional cloning
54. Menkes disease: Underlying genetic defect and new diagnostic possibilities
55. Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency
56. Genetic disorders of membrane transport. IV. Wilson's disease and Menkes disease
57. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutast
58. The ATX1 gene of Saccharomyces cerevisiae encodes a small metal homeostasis factor that protects cells against reactive oxygen toxicity
59. A role for the Saccharomyces cerevisiae ATX1 gene in copper trafficking and iron transport
60. Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis
61. Structure, expression and chromosomal localization of the Mouse Atox1 gene
62. HAH1 is a copper-binding protein with distinct amino acid residues mediating copper homeostasis and antioxidant defense
63. Crystal structure of the Atx1 metallochaperone protein at 1.02 A resolution
64. Metal ion chaperone function of the soluble Cu(I) receptor, Atx1
65. Characterization of the interaction between the Wilson's and Menkes disease proteins and the cytoplasmic copper chaperone, HAH1p
66. Interaction of the copper chaperone HAH1 with the Wilson's disease protein is essential for copper homeostasis
67. Functional characterization of missense mutations in ATP7B: Wilson's disease mutation or normal variant?
68. Functional expression of the Wilson's disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation
69. Identification of a di-leucine motif within the C terminus domain of the menkes disease protein that mediates endocytosis from the plasma membrane
70. The Menkes protein (ATP7A; MNK) cycles via the plasma membrane both in basal and elevated extracellular copper using a C-terminal di-leucine endocytic signal
71. Further delineation of the molecular pathology of Wilson's disease in the Mediterranean population
72. Wilson's disease: Update on a systemic disorder with protean manifestations
73. The yeast CLC chloride channel functions in cation homeostasis
74. Chloride is an allosteric effector of copper assembly for the yeast multicopper oxidase fet3p: An unexpected role for intracellular chloride channels
75. Genetic heterogeneity in Wilson's disease: Lessons from rare alleles
76. The toxic milk, a new mutation affecting copper metabolism in the mouse
77. The toxic milk mouse is a murine model of Wilson's disease
78. Null mutation of the murine ATP7B (Wilson's disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation
79. The LEC rat has a deletion in the copper transporting ATPase genehomologous to the Wilson's disease gene
80. Spontaneous hepatic copper accumulation in Long Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease
81. Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA
82. Biliary excretion of copper in LEC rat after introduction of copper transporting P-type ATPase, ATP7B
83. Hepatic iron deprivation prevents spontaneous development of fulminat hepatitis and liver cancer in Long Evans Cinnamon rats
84. Wilson disease: Genetic basis of copper toxicity and natural history
85. Genetic liver disease in adults. Early recognition of the three most common causes
86. Diagnosis of Wilson's disease: An experience over three decades
87. Wilson's disease: A new gene and an animal model for an old disease
88. Wilson's disease presenting with features of hepatic dysfunction: A clinical analysis of eighty-seven patients
89. Liver transplantation for Wilson's disease: Indications and outcome
90. Hepatic morphology and histochemistry of Wilson's disease presenting as fulminant hepatic failure: A study of 11 cases
91. Neurologic and neuropsychiatric spectrum of Wilson's disease: A prospective study of 45 cases
92. Magnetic resonance imaging and proton MR spectroscopy in Wilson's disease
93. Wilson's disease: Psychiatric symptoms in 195 cases
94. Wilson's disease in patients presenting with liver disease: A diagnostic challenge
95. Overcoming obstacles to the diagnosis of Wilson's disease
96. Present interpretation of the role of copper in Indian childhood cirrhosis
97. Endemic Tyrolean infantile cirrhosis: An ecogenetic disorder
98. Aceruloplasminemia
99. Detection of the His1069G1n mutation in Wilson's disease by rapid polymerase chain reaction
100. Molecular advances in Wilson's disease
101. Reversible magnetic resonance imaging lesions in Wilson's disease: Clinical-anatomical correlation
102. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease
103. Treatment of Wilson's disease with trientine (triethylene tetramine)
104. Wilson's disease and pregnancy
105. Liver transplantation: Treatment of choice for hepatic and neurological manifestation of Wilson's disease
106. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease